Eurofins Scientific SE - Asset Resilience Ratio
Eurofins Scientific SE (ERF) has an Asset Resilience Ratio of 7.20% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Eurofins Scientific SE's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2025)
This chart shows how Eurofins Scientific SE's Asset Resilience Ratio has changed over time. See ERF net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Eurofins Scientific SE's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Eurofins Scientific SE.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €791.00 Million | 7.2% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €791.00 Million | 7.20% |
Asset Resilience Insights
- Limited Liquidity: Eurofins Scientific SE maintains only 7.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Eurofins Scientific SE Industry Peers by Asset Resilience Ratio
Compare Eurofins Scientific SE's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Fleury S.A.
SA:FLRY3 |
Diagnostics & Research | 16.06% |
|
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
Diagnostics & Research | 0.12% |
|
Spectral Med Inc
TO:EDT |
Diagnostics & Research | 11.67% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Genetic Signatures Ltd
AU:GSS |
Diagnostics & Research | 60.91% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Annual Asset Resilience Ratio for Eurofins Scientific SE (2004–2025)
The table below shows the annual Asset Resilience Ratio data for Eurofins Scientific SE.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.29% | €251.60 Million ≈ $294.15 Million |
€10.98 Billion ≈ $12.84 Billion |
+1.53pp |
| 2024-12-31 | 0.77% | €83.30 Million ≈ $97.39 Million |
€10.89 Billion ≈ $12.73 Billion |
-3.61pp |
| 2023-12-31 | 4.38% | €476.40 Million ≈ $556.96 Million |
€10.89 Billion ≈ $12.73 Billion |
+3.30pp |
| 2022-12-31 | 1.08% | €108.80 Million ≈ $127.20 Million |
€10.08 Billion ≈ $11.79 Billion |
+0.71pp |
| 2021-12-31 | 0.37% | €34.80 Million ≈ $40.68 Million |
€9.33 Billion ≈ $10.91 Billion |
+0.17pp |
| 2020-12-31 | 0.20% | €17.40 Million ≈ $20.34 Million |
€8.58 Billion ≈ $10.03 Billion |
+0.16pp |
| 2019-12-31 | 0.05% | €3.60 Million ≈ $4.21 Million |
€7.82 Billion ≈ $9.15 Billion |
-0.30pp |
| 2018-12-31 | 0.34% | €24.60 Million ≈ $28.76 Million |
€7.21 Billion ≈ $8.42 Billion |
-2.29pp |
| 2017-12-31 | 2.63% | €153.29 Million ≈ $179.22 Million |
€5.83 Billion ≈ $6.82 Billion |
-9.63pp |
| 2016-12-31 | 12.25% | €506.02 Million ≈ $591.59 Million |
€4.13 Billion ≈ $4.83 Billion |
-3.72pp |
| 2015-12-31 | 15.98% | €591.10 Million ≈ $691.06 Million |
€3.70 Billion ≈ $4.33 Billion |
+12.04pp |
| 2014-12-31 | 3.94% | €73.83 Million ≈ $86.31 Million |
€1.87 Billion ≈ $2.19 Billion |
-8.19pp |
| 2013-12-31 | 12.13% | €181.62 Million ≈ $212.34 Million |
€1.50 Billion ≈ $1.75 Billion |
+11.18pp |
| 2012-12-31 | 0.95% | €11.02 Million ≈ $12.88 Million |
€1.16 Billion ≈ $1.36 Billion |
+2.04pp |
| 2007-12-31 | -1.09% | €-6.67 Million ≈ $-7.80 Million |
€612.02 Million ≈ $715.52 Million |
+0.20pp |
| 2006-12-31 | -1.29% | €-5.93 Million ≈ $-6.94 Million |
€460.34 Million ≈ $538.18 Million |
-1.10pp |
| 2004-12-31 | -0.18% | €-351.00K ≈ $-410.36K |
€190.12 Million ≈ $222.28 Million |
-- |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more